3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Thymus Neoplasms
1
Neuroendocrine Tumors
1
Interventions
olaparib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
lutetium Lu 177 dotatate
1
belzutifan
1
Temozolomide
1
Nivolumab
1
Ipilimumab
1
Fluorodeoxyglucose F18
1
Contrast Media
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraganglioma
×
177Lu-octreotide, DOTA(0)-Tyr(3)-
×
30 days
×
Clear all
No trials found.